BMTI Financial Facts
Research and development: 1.93MLoss from operations: -4.61M
See Full Income Statement
Prepaid expenses: 568.35K
Capital lease obligations: 67.64K
See Full Balance Sheet
BioMimetic Therapeutics Inc. (BMTI) Earnings
|
Expand Research on BMTI
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +8.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -11.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/5/12 | Q312 | -$0.16 | -$0.23 | +$0.07 | $688.7K | $390K | N/A |  | | Details | |
| 5/9/12 | Q112 | -$0.22 | N/A | N/A | $466.38M | $398.7M | N/A | | | Details | |
| 3/13/12 | Q411 | -$0.35 | -$0.26 | -$0.09 | $458K | $310K | N/A | | | Details | |
11/8/11  |
 |
Q311 | -$0.25 | -$0.31 | +$0.06 | $428M | $350K | N/A | | | Details |
| 5/9/11 |
Q111 | -$0.28 | -$0.35 | +$0.07 | $390K | $210K | N/A | | | Details | |
| 3/10/11 |
|
Q410 | -$0.36 | -$0.34 | -$0.02 | $400K | $380K | N/A | | | Details |
